Micropep technologies (Micropep) has raised EUR 8.5 million (USD 10 million) in an oversubscribed Series A investment led by new investor Supernova Invest with participation from FMC Ventures, and existing investors Sofinnova Partners and IRDI Capital Investissement.
Based in Toulouse, France, Micropep was spun out from Centre national de la recherche scientifique (CNRS) and Toulouse University in 2016, a centre of excellence for AgriTech. The company has developed a proprietary technology to precisely enhance plant traits without altering DNA by spraying “miPEPs”, a unique family of natural peptides regulating plant microRNAs.
miPEPs will influence all plant phenotypes regulated by microRNAs including, germination, early growth, disease resistance and flowering. Leveraging the potential of these natural peptides, the company is now developing a pipeline of “sprayable traits” biosolutions to control resistant weeds such as Palmer Amaranth and protect plants against major diseases, primarily targeting the $28 billion American and European herbicides and fungicides markets.
Romain Sautrau, Investment Director at Supernova Invest will join the Board of Directors and Sara Olson, Principal at FMC Ventures, along with Jean-Michel Petit, Investment Director at IRDI Capital Investissement will be joining as Observers to the Board.
“In an industry that has been challenged by a shrinking discovery pipeline, active ingredients that are slowly being phased out and increased pest and weeds resistance to chemicals, our technology provides a ground-breaking alternative. Peptides and small proteins have a great potential for sustainable crop protection solutions and Micropep is proud to lead the field in this area. Using our proprietary discovery platform we can improve plant health naturally, using the plant’s own mechanisms, identifying novel and safe active ingredients with a100x better hit rate compared with conventional methods. This financing will allow us to begin field testing of our promising compounds, the next milestone in commercialising our product.”
Thomas Laurent – MicroPEP CEO
“Micropep’s cutting edge technology has the potential to disrupt tomorrow’s agriculture. As a committed investor in promising deeptech companies, we look forward to leveraging our extensive experience in AgriTech to back Thomas and his best-in-class platform in order to build a new market leader.”
Romain Sautrau, Investment Director at Supernova Invest
“We are delighted to see the progress at Micropep, a company where Sofinnova was the first investor. We look forward to working with this talented team and group of renowned investors as Micropep continues to validate and scale up its exciting technology targeting disease control and weed suppression.”
Denis Lucquin, Partner and Senior Advisor at Sofinnova Partners
“Micropep’s pioneering technology can enhance plant traits without altering plant DNA and circumvents the challenges of GMOs and costs of RNAi. This novel approach has the potential to develop first-in-class biological ‘traits’ – a game changer set against a landscape of regulatory headwinds, emerging resistance, and a global push for sustainable crop protection technologies.”
Amar Singh, Managing Director of FMC Ventures
“The success of the latest fundraising round confirms the confidence of our world-class syndicate of investors in Micropep’s exceptional potential to radically transform agriculture with unique and differentiated biosolutions which will contribute to satisfying consumer demand for improved food safety.”
Kevin Smith, Chairman of the Board of MicroPEP Directors